Allgens(SH:688613) Sou Hu Cai Jing·2025-09-18 00:37Core Viewpoint - The stock of Aojing Medical (688613) has experienced a decline of 2.52% as of September 17, 2025, closing at 27.8 yuan, with significant net outflows from retail investors and a mixed performance in institutional and speculative trading [1][2]. Group 1: Stock Performance and Trading Data - On September 17, 2025, Aojing Medical's stock closed at 27.8 yuan, down 2.52%, with a turnover rate of 7.11% and a trading volume of 97,400 hands, resulting in a transaction amount of 271 million yuan [1]. - The net inflow of institutional funds was 26.25 million yuan, accounting for 9.68% of the total transaction amount, while speculative funds saw a net outflow of 9.54 million yuan (3.52%), and retail investors had a net outflow of 16.71 million yuan (6.16%) [1][2]. Group 2: Financing and Margin Trading Data - On September 17, 2025, the financing buy-in was 21.97 million yuan, while the financing repayment was 32.39 million yuan, resulting in a net repayment of 10.42 million yuan [2][3]. - The total margin trading balance stood at 142 million yuan, with no shares sold or repaid in the short selling segment [2][3]. Group 3: Company Financials and Industry Comparison - Aojing Medical reported a main business revenue of 100 million yuan for the first half of 2025, a year-on-year decrease of 0.2%, and a net profit attributable to shareholders of 7.98 million yuan, down 13.52% year-on-year [5]. - The company’s gross profit margin was 63.12%, significantly higher than the industry average of 51.85%, while its net profit margin was 5.53%, lower than the industry average of 10.39% [5]. - Aojing Medical's total market capitalization is 3.809 billion yuan, with a net asset value of 1.444 billion yuan, and it ranks 94th in the industry based on market capitalization [5].